Online edition of India's National Newspaper
Sunday, Jan 21, 2007
ePaper
Google



Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary |



Business Printer Friendly Page   Send this Article to a Friend

Orchid Q3 net at Rs. 28 cr.

Corporate Reporter

CHENNAI: Pharma major Orchid Chemicals and Pharmaceuticals (Orchid) has reported a turnover and operating income of Rs. 238.73 crore for the quarter ended December 31, 2006, in comparison to Rs. 237.60 crore registered during the corresponding third quarter of the last fiscal. The gross profit before interest, depreciation and tax stood at Rs. 78.11 crore as compared to Rs. 69.76 crore in the year-ago period. The net profit after tax stood at Rs. 28.32 crore against Rs. 28.96 crore of the corresponding quarter of the last fiscal.

The third quarter of this fiscal has witnessed a further consolidation and growth in the U.S. business based on ramp-up of the notable product introductions made earlier. Ceftriaxone, Cefprozil, Cefazolin and Cefoxitin continued to be key growth drivers, says a company release.

Printer friendly page  
Send this article to Friends by E-Mail



Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |

Copyright 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu